Navigation Links
Don't Believe What You Hear on Countdown: Keith Olbermann's Factual Errors
Date:2/17/2009

NEW YORK, Feb. 17 /PRNewswire-USNewswire/ -- The following is from Betsy McCaughey, Ph.D., the author of the recent Bloomberg.com article, "Ruin Your Health With the Obama Stimulus Plan."

I am requesting that MSNBC and Keith Olbermann apologize and issue a correction.

Mr. Olbermann charges that I, Betsy McCaughey, Ph.D. was paid, directly or indirectly, by the pharmaceutical industry, the biotech industry, the Hudson Institute, or Cantel Medical Corp. to write my analysis of the stimulus bill or speak about that issue. All these charges are false.

I have shown all these charges to be false in a previous statement except the new charge regarding my board membership at Cantel Medical Corp. I serve on the board of Cantel Medical Corp. as a patient advocate and infection prevention expert. No one at Cantel Medical has ever asked me about the stimulus bill or requested that I address the issue. I have not discussed the issue with anyone in the company. I urge those who are interested to contact Cantel Medical directly (973-890-7220).

I have purchased no stock in Cantel Medical. Like all board members, I am routinely issued options. The options cited by Keith Olbermann were not issued to me in payment for my work on the stimulus bill. They were issued to all Cantel board members at the same time. They are issued routinely and periodically. Unlike the other board members, I have never exercised any options to purchase stock. I do not use those options to make money. The same is true for other boards on which I have served.

Sincerely,

Betsy McCaughey, Ph.D.


'/>"/>
SOURCE Betsy McCaughey
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Interleukin Genetics to Present at the 13th International Conference on Periodontal Research
2. Ondine Announces Presentation of Positive Clinical Trial Results at the American Academy of Periodontologys 94th Annual Meeting
3. Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
4. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
5. Affitech Appoints Dr. Keith McCullagh as Chairman
6. Surface Logix Appoints Keith Dionne as President and Chief Executive Officer
7. New Wireless ID Skin Patch Technology Designed to Reduce Medical Errors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... ... 2017 , ... MacArthur Sotheby’s International Realty, a luxury real ... the first Delos Wellness Signature™ residence in Hawaii is on the market for ... listing agent Kelly Allen, R(S) of Carvill Sotheby’s International Realty located on Oahu, ...
(Date:8/21/2017)... Boston, MA (PRWEB) , ... August 21, 2017 ... ... healthcare consulting firm is utilizing its extensive experience with Health Economics and Outcomes ... on Electronic Health Record data. In 2014, US healthcare spending exceeded $3.0 trillion ...
(Date:8/18/2017)... ... August 18, 2017 , ... Producers of ... Federal Hybrids, Inc. in an upcoming episode, scheduled to broadcast fourth quarter 2017. ... explore Federal Hybrids, the independent, family-owned seed company. Educating audiences about its broad ...
(Date:8/17/2017)... ... August 17, 2017 , ... Cynvenio Biosystems, ... today announced the launch of a new breast cancer monitoring study in partnership ... to evaluate the potential for early detection of recurrent breast cancer using LiquidBiopsy ...
Breaking Biology Technology:
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... to grow at a CAGR of 30.37% during the period 2017-2021. ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
Breaking Biology News(10 mins):